Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 publications Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

Autoimmune Disorders

Free Subscription 25.05.2020 2 Acta Neurol Scand 1 Am J Kidney Dis 1 Ann Neurol 2 BMC Neurol 2 Brain 1 Intern Med 1 J Autoimmun 4 J Clin Endocrinol Metab 1 J Immunol 1 J Neuroimmunol 1 J Neurol 1 J Pediatr 1 J Pediatr Endocrinol Metab 1 J Rheumatol 1 Lancet Child Adolesc Health 1 Lancet Diabetes Endocrinol 1 Mult Scler 3 N Engl J Med 7 Neurology 1 PLoS Med 1 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neurol Scand

1. ZANONI M, Orlandi E, Rossetti G, Turatti M, et al
   Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
   Acta Neurol Scand. 2020 May 20. doi: 10.1111/ane.13288.
   PubMed         Abstract available
   
   
2. ZHU F, Shan W, Lv R, Li Z, et al
   Clinical characteristics of GAD 65 associated autoimmune encephalitis.
   Acta Neurol Scand. 2020 May 16. doi: 10.1111/ane.13281.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

3. EL TERS M, Bobart SA, Cornell LD, Leung N, et al
   Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series.
   Am J Kidney Dis. 2020 May 12. pii: S0272-6386(20)30571.
   PubMed         Abstract available
   
   

   
   Ann Neurol

4. MAGLIOZZI R, Scalfari A, Pisani AI, Ziccardi S, et al
   The CSF profile linked to cortical damage predicts Multiple Sclerosis activity.
   Ann Neurol. 2020 May 17. doi: 10.1002/ana.25786.
   PubMed         Abstract available
   
   

   
   BMC Neurol

5. BRANCO M, Alves I, Martins da Silva A, Pinheiro J, et al
   The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study.
   BMC Neurol. 2020;20:195.
   PubMed         Abstract available
   
   
6. KHALIGH-RAZAVI SM, Sadeghi M, Khanbagi M, Kalafatis C, et al
   A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).
   BMC Neurol. 2020;20:193.
   PubMed         Abstract available
   
   

   
   Brain

7. KADOWAKI A, Quintana FJ
   The NLRP3 inflammasome in progressive multiple sclerosis.
   Brain. 2020;143:1286-1288.
   PubMed        
   
   
8. RAMBERGER M, Berretta A, Tan JMM, Sun B, et al
   Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
   Brain. 2020 May 21. pii: 5841730. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Intern Med

9. FURUYA MY, Watanabe H, Sato S, Fujita Y, et al
   An Autopsy Case of Mixed Connective Tissue Disease Complicated by Thrombotic Thrombocytopenic Purpura.
   Intern Med. 2020;59:1315-1321.
   PubMed         Abstract available
   
   

   
   J Autoimmun

10. YANG Y, Peng F, Wang R, Yang M, et al
    Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].
    J Autoimmun. 2020 May 15:102487. doi: 10.1016/j.jaut.2020.102487.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

11. CREE-GREEN M, Bergman BC, Cengiz E, Fox LA, et al
    Metformin Improves Peripheral Insulin Sensitivity in Youth with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Apr 2. pii: 5423566. doi: 10.1210/jc.2019-00129.
    PubMed         Abstract available
    
    
12. EBERT A, Konig J, Frommer L, Schuppan D, et al
    Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.
    J Clin Endocrinol Metab. 2020 May 21. pii: 5841628. doi: 10.1210.
    PubMed         Abstract available
    
    
13. BELLASTELLA G, Maiorino MI, Cirillo P, Longo M, et al
    Remission of Pituitary Autoimmunity Induced by Gluten-Free Diet in Patients With Celiac Disease.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available
    
    
14. PEARCE EN
    Thyroid autoimmunity is associated with postpartum thyroiditis risk, even in women with treated hypothyroidism.
    J Clin Endocrinol Metab. 2020 May 18. pii: 5839887. doi: 10.1210.
    PubMed        
    
    

    
    J Immunol

15. QIU R, Yu X, Wang L, Han Z, et al
    Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR -21-Peli1-c-Rel Pathway Prevents Autoimmunity.
    J Immunol. 2020 May 15. pii: jimmunol.2000060. doi: 10.4049/jimmunol.2000060.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

16. KAPADIA RK, Ney DE, Hannan M, Farley M, et al
    Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.
    J Neuroimmunol. 2020;344:577259.
    PubMed         Abstract available
    
    

    
    J Neurol

17. GIGLI GL, Bax F, Marini A, Pellitteri G, et al
    Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?
    J Neurol. 2020 May 19. pii: 10.1007/s00415-020-09911.
    PubMed        
    
    

    
    J Pediatr

18. RASMUSSEN VF, Vestergaard ET, Schwandt A, Beltrand J, et al
    Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    J Pediatr. 2019 Jul 22. pii: S0022-3476(19)30696.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

19. DIMOVA R, Grozeva G, Chakarova N, Tsarkova P, et al
    GAD-65 autoantibody associated epilepsy.
    J Pediatr Endocrinol Metab. 2020.
    PubMed         Abstract available
    
    

    
    J Rheumatol

20. STAMATIS P, Turkiewicz A, Englund M, Jonsson G, et al
    Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden.
    J Rheumatol. 2020 May 15. pii: jrheum.200211. doi: 10.3899/jrheum.200211.
    PubMed         Abstract available
    
    

    
    Lancet Child Adolesc Health

21. CAMERON FJ, Northam EA, Ryan CM
    The effect of type 1 diabetes on the developing brain.
    Lancet Child Adolesc Health. 2019 Apr 12. pii: S2352-4642(19)30055.
    PubMed         Abstract available
    
    

    
    Lancet Diabetes Endocrinol

22. TAYLOR SI, Blau JE, Rother KI, Beitelshees AL, et al
    SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks.
    Lancet Diabetes Endocrinol. 2019 Oct 1. pii: S2213-8587(19)30154.
    PubMed         Abstract available
    
    

    
    Mult Scler

23. WANG FM, Davis MF, Briggs FB
    Predicting self-reported depression after the onset of multiple sclerosis using genetic and non-genetic factors.
    Mult Scler. 2020 May 18:1352458520921073. doi: 10.1177/1352458520921073.
    PubMed         Abstract available
    
    

    
    N Engl J Med

24. DOUGLAS RS, Kahaly GJ
    Teprotumumab for Active Thyroid Eye Disease. Reply.
    N Engl J Med. 2020;382:1959-1960.
    PubMed        
    
    
25. ROOS JCP, Hyry HI, Murthy R
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1959.
    PubMed        
    
    
26. KIM S, Patzek S
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1958-1959.
    PubMed        
    
    

    
    Neurology

27. SYRBE S, Stettner GM, Bally J, Borggraefe I, et al
    CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
    Neurology. 2020 May 18. pii: WNL.0000000000009523.
    PubMed         Abstract available
    
    
28. DALE RC, Rostasy K
    Autoimmune pediatric neuropsychiatric symptoms with pain and hypertension: CASPR2 antibody.
    Neurology. 2020 May 18. pii: WNL.0000000000009521.
    PubMed        
    
    
29. LANDMEYER NC, Burkner PC, Wiendl H, Ruck T, et al
    Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
    Neurology. 2020 May 19. pii: WNL.0000000000009522.
    PubMed         Abstract available
    
    
30. MANOUCHEHRINIA A, Stridh P, Khademi M, Leppert D, et al
    Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis.
    Neurology. 2020 May 20. pii: WNL.0000000000009571.
    PubMed         Abstract available
    
    
31. LIPKA AF, Boldingh MI, van Zwet EW, Schreurs MWJ, et al
    Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.
    Neurology. 2020;94:e511-e520.
    PubMed         Abstract available
    
    
32. KAPOOR M, Spillane J, Englezou C, Sarri-Gonzalez S, et al
    Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.
    Neurology. 2020;94:e635-e638.
    PubMed         Abstract available
    
    
33. MACARON G, Willis MA, Ontaneda D, Fernandez H, et al
    Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.
    Neurology. 2020;94:273-275.
    PubMed        
    
    

    
    PLoS Med

34. LUK AOY, Ke C, Lau ESH, Wu H, et al
    Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study.
    PLoS Med. 2020;17:e1003052.
    PubMed         Abstract available
    
    

    
    PLoS One

35. YALACHKOV Y, Uhlmann V, Bergmann J, Soydas D, et al
    Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance.
    PLoS One. 2020;15:e0228679.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

36. KHAN Z, Di Nucci F, Kwan A, Hammer C, et al
    Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer.
    Proc Natl Acad Sci U S A. 2020 May 19. pii: 1922867117.
    PubMed         Abstract available
    
    
37. MALINOW R, Klein ME
    Reply to Hashimoto: Ketamine is not an opioid but requires opioid system for antidepressant actions.
    Proc Natl Acad Sci U S A. 2020 May 19. pii: 2002739117.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: